Russia has released the first batch of Sputnik V, the world's first coronavirus vaccine for its citizens. The Russian Ministry of Health stated that this Russian vaccine has passed all quality checks and has now been released for citizens. The clinical trial of the third phase of the Russian vaccine is going to start this week.
Earlier on Sunday, the Mayor of Moscow, Sergei Sobyanin, had hoped that most people in the capital would be given the Coronavirus vaccine within the next few months. The clinical trial of the last phase of Russia's Coronavirus vaccine Sputnik V will start in India from this month. Kirill Dimitrij, CEO of the Russian Direct Investment Fund, the funding agency for the vaccine, said clinical trials for the vaccine would begin in India, including India, in the UAE, Saudi Arabia, the Philippines and Brazil this month.
He also said that the primary results of the clinical trial of the third phase of the vaccine will be released in October-November. This coronavirus vaccine was launched by Russian President Vladimir Putin on 11 August. The vaccine has been developed by the Gamaleya Research Institute of Moscow in collaboration with the Russian Ministry of Defense.
Russia reported that mass production of the vaccine was expected to begin in September 2020. In future plans, it is targeted to make 200 million doses of this vaccine by the end of 2020. 30 million of this vaccine will be for Russians only.
How does the Russian Coronavirus vaccine work?
Russia's vaccine is based on the common cold-causing adenovirus. This vaccine has been created in an artificial way. It mimics the structural protein found in the coronavirus SARS-CoV-2, which produces exactly the same immune response in the body as a result of a coronavirus infection. That is, in one way, the human body responds in the same way that it reacts when a coronavirus infection occurs, but it does not have the fatal consequences of Covid-19. Clinical trials began on 18 June at the University of Moscow's Seshenov. In a study done on 38 people, the vaccine has been found safe. Immunity against viruses has also been found in all volunteers.